Rates of Grade 4 Event Types by Latest CD4 Count (cells/mm3) and ART Status: Morbidity and Mortality Cohort.

Age-and Sex-specific Death Rates in ART-naïve Patients with CD4 Count above 350 cells/m³ Compared with the General Population

Lodwick, Rebecca K
Porter, Keith R.
Sabin, Caroline
Ledergerber, Bruno
Cozzi-Lepri, Alessandro
Khaykin, Pavel
Mocroft, Amanda
Jacobson, Lisa
De Wit, Stéphane
Phillips, Andrew N.

February 2008

Study Group on Death Rate at High CD4 Count in Antoretroviral-naïve patientsinfo:eu-repo/semantics/n...

CD4(+) cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, sex and calendar time

Cori, Anne
Pickles, Michael
van Sighem, Ard
Gras, Luuk
Bezemer, Daniela
Reiss, Peter
Fraser, Christophe

January 2015

Background:CD4(+) cell count is a key measure of HIV disease progression, and the basis of successiv...

CD4 cell count and viral load-specific rates of AIDS, non-AIDS and deaths according to current antiretroviral use

Mocroft, Amanda
Phillips, Andrew N
Gatell, Jose
Horban, Andrej
Ledergerber, Bruno
Zilmer, Kai
Jevtovic, Djordje
Maltez, Fernando
Podlekareva, Daria
Lundgren, Jens D

January 2013

BACKGROUND: CD4 cell count and viral loads are used in clinical trials as surrogate endpoints for as...

Relative Rates of Morbidity and Mortality by Latest CD4 Count (cells/mm3) and ART Status: Morbidity and Mortality Cohort.

Patrick H. Maduna (719516)
Matt Dolan (719517)
Lwando Kondlo (719518)
Honey Mabuza (719519)
Judith N. Dlamini (719520)
Mike Polis (719521)
Thabo Mnisi (719522)
Susan Orsega (328934)
Patrick Maja (328929)
Lotty Ledwaba (328926)
Thuthukile Molefe (719523)
Phumelele Sangweni (719524)
Lisette Malan (719525)
Gugu Matchaba (719526)
Paul Khabo (328928)
Greg Grandits (220310)
James D. Neaton (127563)

April 2015

Notes:1 Adjusted for age, gender, history of AIDS or TB, and time-updated viral...

Mortality Rates by Latest CD4 Count (cells/mm3) for Phidisa Participants: Mortality Cohort.

Patrick H. Maduna (719516)
Matt Dolan (719517)
Lwando Kondlo (719518)
Honey Mabuza (719519)
Judith N. Dlamini (719520)
Mike Polis (719521)
Thabo Mnisi (719522)
Susan Orsega (328934)
Patrick Maja (328929)
Lotty Ledwaba (328926)
Thuthukile Molefe (719523)
Phumelele Sangweni (719524)
Lisette Malan (719525)
Gugu Matchaba (719526)
Paul Khabo (328928)
Greg Grandits (220310)
James D. Neaton (127563)

April 2015

Notes: Relative rate estimates obtained using Poisson RegressionAdjusted for age, g...

Event rates in CD4 strata among the 75,336 patients with at least one suppression episode while on cART: event rates per 1,000 y of suppressed viral load (number of events) over time for the primary outcome (a first new AIDS event or death).

The Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord (614233)

March 2012

Event rates in CD4 strata among the 75,336 patients with at least one suppression episode while o...

Incidence rates (per 1000 PYFU) of selected most common OIs stratified by current CD4 cell count in a cohort of patients on ART followed up for 10 years.

Dana Weissberg (5921303)
Frank Mubiru (834536)
Andrew Kambugu (166978)
Jan Fehr (174310)
Agnes Kiragga (293779)
Amrei von Braun (5921306)
Anna Baumann (3363701)
Marisa Kaelin (5921309)
Christine Sekaggya-Wiltshire (4609246)
Moses Kamya (10698)
Barbara Castelnuovo (10700)

November 2018

Incidence rates (per 1000 PYFU) of selected most common OIs stratified by current CD4 cell count in ...

Mortality rates for men and women stratified by baseline CD4+ cell count and age.

Kogieleum Naidoo (558699)
Razia Hassan-Moosa (4433182)
Nonhlanhla Yende-Zuma (385568)
Dhineshree Govender (4433173)
Nesri Padayatchi (47834)
Halima Dawood (694909)
Rochelle Nicola Adams (4433176)
Aveshen Govender (4433164)
Tilagavathy Chinappa (4433170)
Salim Abdool-Karim (4433179)
Quarraisha Abdool-Karim (4433167)

September 2017

Mortality rates for men and women stratified by baseline CD4+ cell count and age.</p

Relative mortality by region and duration on ART comparing European and North American cohorts to South Africa. (A) Crude rates, (B) adjusted for baseline covariates*, (C) corrected for cohort-assessed mortality under-ascertainment** and adjusted for baseline covariates, and (D) limited in Europe and North America to patients with sexual acquisition of HIV, adjusted for baseline covariates.

Andrew Boulle (93997)
Michael Schomaker (138489)
Margaret T. May (627545)
Robert S. Hogg (118028)
Bryan E. Shepherd (173791)
Susana Monge (437404)
Olivia Keiser (93991)
Fiona C. Lampe (470943)
Janet Giddy (25207)
James Ndirangu (291392)
Daniela Garone (383442)
Matthew Fox (361722)
Suzanne M. Ingle (627546)
Peter Reiss (4933)
Francois Dabis (3141000)
Dominique Costagliola (131086)
Antonella Castagna (255402)
Kathrin Ehren (627547)
Colin Campbell (527529)
M. John Gill (341799)
Michael Saag (170633)
Amy C. Justice (229955)
Jodie Guest (627548)
Heidi M. Crane (627549)
Matthias Egger (24558)
Jonathan A. C. Sterne (123321)

September 2014

*Adjusted for baseline gender, CD4 count, clinical stage, viral load, and calendar period. **In o...

Cox proportion hazard regression modelling outcome: CD4≤250, WHO clinical stage 4 and death.

Deogratius Ssemwanga (444460)
Rebecca N. Nsubuga (322027)
Billy N. Mayanja (444461)
Frederick Lyagoba (444462)
Brian Magambo (444463)
Dave Yirrell (444464)
Lieve Van der Paal (350457)
Heiner Grosskurth (37057)
Pontiano Kaleebu (62293)

August 2013

&With subtype A as baseline.&&Baseline CD4 counts scaled by 100.*Analysis for WHO s...

Trends in median CD4 count and proportion of patients with CD4 count > 400 cells/μL over 10 years of follow up on ART.

Barbara Castelnuovo (10700)
Agnes Kiragga (293779)
Joseph Musaazi (834535)
Joseph Sempa (455277)
Frank Mubiru (834536)
Jane Wanyama (834537)
Bonnie Wandera (736998)
Moses Robert Kamya (834538)
Andrew Kambugu (166978)

December 2015

Trends in median CD4 count and proportion of patients with CD4 count > 400 cells/μL over 10 years...

Estimated probability of falling below a CD4 count of 750 cells/mm3 or a CD4 percentage of 25%.

Michael Schomaker (138489)
Matthias Egger (24558)
James Ndirangu (291392)
Sam Phiri (283102)
Harry Moultrie (355765)
Karl Technau (487000)
Vivian Cox (487001)
Janet Giddy (25207)
Cleophas Chimbetete (487002)
Robin Wood (4924)
Thomas Gsponer (383441)
Carolyn Bolton Moore (487003)
Helena Rabie (487004)
Brian Eley (370977)
Lulu Muhe (325530)
Martina Penazzato (314512)
Shaffiq Essajee (363292)
Olivia Keiser (93991)
Mary-Ann Davies (378311)

November 2013

(A) Time to fall below the CD4 threshold of a CD4 count of 750 cells/mm3 or a CD4% of ...

Mortality by Latest CD4+ Cell Count and ART status for Phidisa Participants.

Patrick H. Maduna (719516)
Matt Dolan (719517)
Lwando Kondlo (719518)
Honey Mabuza (719519)
Judith N. Dlamini (719520)
Mike Polis (719521)
Thabo Mnisi (719522)
Susan Orsega (328934)
Patrick Maja (328929)
Lotty Ledwaba (328926)
Thuthukile Molefe (719523)
Phumelele Sangweni (719524)
Lisette Malan (719525)
Gugu Matchaba (719526)
Paul Khabo (328928)
Greg Grandits (220310)
James D. Neaton (127563)

April 2015

Mortality by Latest CD4+ Cell Count and ART status for Phidisa Participants.</p

A novel approach to accounting for loss to follow-up when estimating the relationship between CD4 Count at ART initiation and mortality.

Matthew Fox
Owen McCarthy
Mead Over

While CD4 strongly predicts mortality on antiretroviral therapy (ART), estimates from programmatic d...

A Novel Approach to Accounting for Loss to Follow-Up when Estimating the Relationship between CD4 Count at ART Initiation and Mortality

Fox Matthew
McCarthy Owen
Over Mead

July 2013

While CD4 strongly predicts mortality on antiretroviral therapy (ART), estimates from programmatic d...

Age-and Sex-specific Death Rates in ART-naïve Patients with CD4 Count above 350 cells/m³ Compared with the General Population

Lodwick, Rebecca K
Porter, Keith R.
Sabin, Caroline
Ledergerber, Bruno
Cozzi-Lepri, Alessandro
Khaykin, Pavel
Mocroft, Amanda
Jacobson, Lisa
De Wit, Stéphane
Phillips, Andrew N.

February 2008

Study Group on Death Rate at High CD4 Count in Antoretroviral-naïve patientsinfo:eu-repo/semantics/n...

CD4(+) cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, sex and calendar time

Cori, Anne
Pickles, Michael
van Sighem, Ard
Gras, Luuk
Bezemer, Daniela
Reiss, Peter
Fraser, Christophe

January 2015

Background:CD4(+) cell count is a key measure of HIV disease progression, and the basis of successiv...

CD4 cell count and viral load-specific rates of AIDS, non-AIDS and deaths according to current antiretroviral use

Mocroft, Amanda
Phillips, Andrew N
Gatell, Jose
Horban, Andrej
Ledergerber, Bruno
Zilmer, Kai
Jevtovic, Djordje
Maltez, Fernando
Podlekareva, Daria
Lundgren, Jens D

January 2013

BACKGROUND: CD4 cell count and viral loads are used in clinical trials as surrogate endpoints for as...

Relative Rates of Morbidity and Mortality by Latest CD4 Count (cells/mm3) and ART Status: Morbidity and Mortality Cohort.

Patrick H. Maduna (719516)
Matt Dolan (719517)
Lwando Kondlo (719518)
Honey Mabuza (719519)
Judith N. Dlamini (719520)
Mike Polis (719521)
Thabo Mnisi (719522)
Susan Orsega (328934)
Patrick Maja (328929)
Lotty Ledwaba (328926)
Thuthukile Molefe (719523)
Phumelele Sangweni (719524)
Lisette Malan (719525)
Gugu Matchaba (719526)
Paul Khabo (328928)
Greg Grandits (220310)
James D. Neaton (127563)

April 2015

Notes:1 Adjusted for age, gender, history of AIDS or TB, and time-updated viral...

Mortality Rates by Latest CD4 Count (cells/mm3) for Phidisa Participants: Mortality Cohort.

Patrick H. Maduna (719516)
Matt Dolan (719517)
Lwando Kondlo (719518)
Honey Mabuza (719519)
Judith N. Dlamini (719520)
Mike Polis (719521)
Thabo Mnisi (719522)
Susan Orsega (328934)
Patrick Maja (328929)
Lotty Ledwaba (328926)
Thuthukile Molefe (719523)
Phumelele Sangweni (719524)
Lisette Malan (719525)
Gugu Matchaba (719526)
Paul Khabo (328928)
Greg Grandits (220310)
James D. Neaton (127563)

April 2015

Notes: Relative rate estimates obtained using Poisson RegressionAdjusted for age, g...

Event rates in CD4 strata among the 75,336 patients with at least one suppression episode while on cART: event rates per 1,000 y of suppressed viral load (number of events) over time for the primary outcome (a first new AIDS event or death).

The Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord (614233)

March 2012

Event rates in CD4 strata among the 75,336 patients with at least one suppression episode while o...

Incidence rates (per 1000 PYFU) of selected most common OIs stratified by current CD4 cell count in a cohort of patients on ART followed up for 10 years.

Dana Weissberg (5921303)
Frank Mubiru (834536)
Andrew Kambugu (166978)
Jan Fehr (174310)
Agnes Kiragga (293779)
Amrei von Braun (5921306)
Anna Baumann (3363701)
Marisa Kaelin (5921309)
Christine Sekaggya-Wiltshire (4609246)
Moses Kamya (10698)
Barbara Castelnuovo (10700)

November 2018

Incidence rates (per 1000 PYFU) of selected most common OIs stratified by current CD4 cell count in ...

Mortality rates for men and women stratified by baseline CD4+ cell count and age.

Kogieleum Naidoo (558699)
Razia Hassan-Moosa (4433182)
Nonhlanhla Yende-Zuma (385568)
Dhineshree Govender (4433173)
Nesri Padayatchi (47834)
Halima Dawood (694909)
Rochelle Nicola Adams (4433176)
Aveshen Govender (4433164)
Tilagavathy Chinappa (4433170)
Salim Abdool-Karim (4433179)
Quarraisha Abdool-Karim (4433167)

September 2017

Mortality rates for men and women stratified by baseline CD4+ cell count and age.</p

Relative mortality by region and duration on ART comparing European and North American cohorts to South Africa. (A) Crude rates, (B) adjusted for baseline covariates*, (C) corrected for cohort-assessed mortality under-ascertainment** and adjusted for baseline covariates, and (D) limited in Europe and North America to patients with sexual acquisition of HIV, adjusted for baseline covariates.

Andrew Boulle (93997)
Michael Schomaker (138489)
Margaret T. May (627545)
Robert S. Hogg (118028)
Bryan E. Shepherd (173791)
Susana Monge (437404)
Olivia Keiser (93991)
Fiona C. Lampe (470943)
Janet Giddy (25207)
James Ndirangu (291392)
Daniela Garone (383442)
Matthew Fox (361722)
Suzanne M. Ingle (627546)
Peter Reiss (4933)
Francois Dabis (3141000)
Dominique Costagliola (131086)
Antonella Castagna (255402)
Kathrin Ehren (627547)
Colin Campbell (527529)
M. John Gill (341799)
Michael Saag (170633)
Amy C. Justice (229955)
Jodie Guest (627548)
Heidi M. Crane (627549)
Matthias Egger (24558)
Jonathan A. C. Sterne (123321)

September 2014

*Adjusted for baseline gender, CD4 count, clinical stage, viral load, and calendar period. **In o...

Cox proportion hazard regression modelling outcome: CD4≤250, WHO clinical stage 4 and death.

Deogratius Ssemwanga (444460)
Rebecca N. Nsubuga (322027)
Billy N. Mayanja (444461)
Frederick Lyagoba (444462)
Brian Magambo (444463)
Dave Yirrell (444464)
Lieve Van der Paal (350457)
Heiner Grosskurth (37057)
Pontiano Kaleebu (62293)

August 2013

&With subtype A as baseline.&&Baseline CD4 counts scaled by 100.*Analysis for WHO s...

Trends in median CD4 count and proportion of patients with CD4 count > 400 cells/μL over 10 years of follow up on ART.

Barbara Castelnuovo (10700)
Agnes Kiragga (293779)
Joseph Musaazi (834535)
Joseph Sempa (455277)
Frank Mubiru (834536)
Jane Wanyama (834537)
Bonnie Wandera (736998)
Moses Robert Kamya (834538)
Andrew Kambugu (166978)

December 2015

Trends in median CD4 count and proportion of patients with CD4 count > 400 cells/μL over 10 years...

Estimated probability of falling below a CD4 count of 750 cells/mm3 or a CD4 percentage of 25%.

Michael Schomaker (138489)
Matthias Egger (24558)
James Ndirangu (291392)
Sam Phiri (283102)
Harry Moultrie (355765)
Karl Technau (487000)
Vivian Cox (487001)
Janet Giddy (25207)
Cleophas Chimbetete (487002)
Robin Wood (4924)
Thomas Gsponer (383441)
Carolyn Bolton Moore (487003)
Helena Rabie (487004)
Brian Eley (370977)
Lulu Muhe (325530)
Martina Penazzato (314512)
Shaffiq Essajee (363292)
Olivia Keiser (93991)
Mary-Ann Davies (378311)

November 2013

(A) Time to fall below the CD4 threshold of a CD4 count of 750 cells/mm3 or a CD4% of ...

Mortality by Latest CD4+ Cell Count and ART status for Phidisa Participants.

Patrick H. Maduna (719516)
Matt Dolan (719517)
Lwando Kondlo (719518)
Honey Mabuza (719519)
Judith N. Dlamini (719520)
Mike Polis (719521)
Thabo Mnisi (719522)
Susan Orsega (328934)
Patrick Maja (328929)
Lotty Ledwaba (328926)
Thuthukile Molefe (719523)
Phumelele Sangweni (719524)
Lisette Malan (719525)
Gugu Matchaba (719526)
Paul Khabo (328928)
Greg Grandits (220310)
James D. Neaton (127563)

April 2015

Mortality by Latest CD4+ Cell Count and ART status for Phidisa Participants.</p

A novel approach to accounting for loss to follow-up when estimating the relationship between CD4 Count at ART initiation and mortality.

Matthew Fox
Owen McCarthy
Mead Over

While CD4 strongly predicts mortality on antiretroviral therapy (ART), estimates from programmatic d...

A Novel Approach to Accounting for Loss to Follow-Up when Estimating the Relationship between CD4 Count at ART Initiation and Mortality

Fox Matthew
McCarthy Owen
Over Mead

July 2013

While CD4 strongly predicts mortality on antiretroviral therapy (ART), estimates from programmatic d...

Age-and Sex-specific Death Rates in ART-naïve Patients with CD4 Count above 350 cells/m³ Compared with the General Population

Lodwick, Rebecca K
Porter, Keith R.
Sabin, Caroline
Ledergerber, Bruno
Cozzi-Lepri, Alessandro
Khaykin, Pavel
Mocroft, Amanda
Jacobson, Lisa
De Wit, Stéphane
Phillips, Andrew N.

February 2008

Study Group on Death Rate at High CD4 Count in Antoretroviral-naïve patientsinfo:eu-repo/semantics/n...

CD4(+) cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, sex and calendar time

Cori, Anne
Pickles, Michael
van Sighem, Ard
Gras, Luuk
Bezemer, Daniela
Reiss, Peter
Fraser, Christophe

January 2015

Background:CD4(+) cell count is a key measure of HIV disease progression, and the basis of successiv...

CD4 cell count and viral load-specific rates of AIDS, non-AIDS and deaths according to current antiretroviral use

Mocroft, Amanda
Phillips, Andrew N
Gatell, Jose
Horban, Andrej
Ledergerber, Bruno
Zilmer, Kai
Jevtovic, Djordje
Maltez, Fernando
Podlekareva, Daria
Lundgren, Jens D

January 2013

BACKGROUND: CD4 cell count and viral loads are used in clinical trials as surrogate endpoints for as...

Rates of Grade 4 Event Types by Latest CD4 Count (cells/mm<sup>3</sup>) and ART Status: Morbidity and Mortality Cohort.

Abstract

Extracted data

Rates of Grade 4 Event Types by Latest CD4 Count (cells/mm<sup>3</sup>) and ART Status: Morbidity and Mortality Cohort.

Abstract

Extracted data

Related items

Related items